Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Phase II trial of ribociclib and everolimus in p16 low anaplastic thyroid cancer (ATC). Tawfik, B., Gerber, D. E., Burtness, B., Hughes, R. S., Myers, L. L., Sumer, B. D., Truelson, J., Strom, T., Kurian, P., Saleem, S., Pearson, J., Zhu, H., Khan, S. A. AMER SOC CLINICAL ONCOLOGY. 2017
View details for DOI 10.1200/JCO.2017.35.15_suppl.TPS6098
View details for Web of Science ID 000411931705094